Myelodysplastic Syndromes Updates From the 2022 ASH Annual Meeting
Results from the MEDALIST, ASCERTAIN, STIMULUS-MDS1, and SINTRA-REV trials may help inform the treatment of MDS.
Please login or register first to view this content.
